Life Science

It has bought 10 of the CUE1 devices from Charco Neurotech.

The company, formerly Cambridge Epigenetix, says it works with any sequencer.

The concept was put forward for consideration in the Local Plan.

An in-depth interview about how the park will evolve - including the prospect of retail within revamped buildings.

Great Shelford and New Orleans-based company expects data in the second quarter.

The work will ultimately have a broad range of precision medicine applications.

GenLink3D platform focuses on the uncharted non-coding regions that make up 98 per cent of the human genome

Councillors voted to support the proposals.

The Babraham Research Campus company is conducting clinical trials in the UK and US.

Mission Street and BentallGreenOak (BGO) will create a 100,000 sq ft site

Nominees across categories from AI to cleantech are revealed.

The awards will be held on May 18.

Sponsored feature | How the companies worked together to create a new genomics site in Histon.

Details of the event can now be announced.

What should start-ups consider?

The new facility will strengthen its offer to the life science industry.

The technology could ultimately help correct harmful mutations in people’s genes.

He will replace Prof Sir Mike Stratton later this year.

Tom Bethell, of Kao Data, writes for the Cambridge Independent.

It follows rapid growth and a rise to prominence for founder Dr Loubna Bouarfa.